Agile's Phase III Data For Twirla Patch Fall Flat, Raise Doubts On Approval

Twirla low-dose birth control patch doesn't work as well in heavier women in Phase III SECURE study, but Agile believes that this is a class effect and an artifact of the stringent, real-world study design requested by FDA.